SV2005002043A - Dispersiones moleculares de drospirenona ref.p-sv-77.901/cd - Google Patents

Dispersiones moleculares de drospirenona ref.p-sv-77.901/cd

Info

Publication number
SV2005002043A
SV2005002043A SV2005002043A SV2005002043A SV2005002043A SV 2005002043 A SV2005002043 A SV 2005002043A SV 2005002043 A SV2005002043 A SV 2005002043A SV 2005002043 A SV2005002043 A SV 2005002043A SV 2005002043 A SV2005002043 A SV 2005002043A
Authority
SV
El Salvador
Prior art keywords
drospirenona
ref
compositions
molecular dispersions
costable
Prior art date
Application number
SV2005002043A
Other languages
English (en)
Inventor
Adrian Funke
Torsten Wagner
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SV2005002043A publication Critical patent/SV2005002043A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

UNA COMPOSICION FARMACEUTICA QUE COMPRENDE DROGAS ESTEROIDES, POR EJEMPLO PROGESTINA Y ESTROGENOS, EN FORMA MOLECULARMAENTE DISPERSA. PREFERIBLEMENTE, LAS COMPOSICIONES SE PROVEEN COMO FORMAS SOLIDAS, SEMISOLIDAS, O LIQUIDAS. DICHAS COMPOSICIONES TIENEN UNA ALTA BIODISPONIBILIDAD, BUENA ESTABILIDAD QUIMICA Y RAPIDA DISOLUCION POR LIBERACION IN VITRO Y SE PUEDEN PRODUCIR EN CONDICIONES QUE NO REQUIREN EQUIPOS COSTOSOS NI RECAUDOS DE SEGURIDAD.TAMBIEN SE DESCRIBEN METODOS PARA LA PREPARACION Y USO DE LAS COMPOSICIONES
SV2005002043A 2004-03-10 2005-03-10 Dispersiones moleculares de drospirenona ref.p-sv-77.901/cd SV2005002043A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04075713 2004-03-10

Publications (1)

Publication Number Publication Date
SV2005002043A true SV2005002043A (es) 2005-11-04

Family

ID=34928104

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2005002043A SV2005002043A (es) 2004-03-10 2005-03-10 Dispersiones moleculares de drospirenona ref.p-sv-77.901/cd

Country Status (12)

Country Link
CN (1) CN1980636A (es)
AR (1) AR048002A1 (es)
DE (1) DE602005022952D1 (es)
GT (1) GT200500044A (es)
MY (1) MY143870A (es)
PA (1) PA8625901A1 (es)
PE (1) PE20060004A1 (es)
RS (1) RS50975B (es)
SV (1) SV2005002043A (es)
TW (2) TW200840587A (es)
UA (1) UA90263C2 (es)
UY (1) UY28802A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106109420B (zh) * 2016-08-11 2018-07-06 吴启旸 依普利酮固体分散体及其制剂

Also Published As

Publication number Publication date
UY28802A1 (es) 2005-10-31
PE20060004A1 (es) 2006-02-16
TW200840587A (en) 2008-10-16
TW200609000A (en) 2006-03-16
CN1980636A (zh) 2007-06-13
RS50975B (sr) 2010-10-31
DE602005022952D1 (de) 2010-09-23
GT200500044A (es) 2005-10-31
UA90263C2 (en) 2010-04-26
AR048002A1 (es) 2006-03-15
MY143870A (en) 2011-07-15
PA8625901A1 (es) 2006-07-03

Similar Documents

Publication Publication Date Title
BRPI0508612A (pt) composições compreendendo drospirenona dispersa molecularmente
UY27641A1 (es) Composiciones farmacéuticas de dispersiones amorfas de fármacos y materiales que forman microfases lipófilas
ECSP066902A (es) Soluciones sólidas supersaturadas estabilizadas de drogas esteroides
MA37809A1 (fr) Administration de médicament biodégradable pour compositions hydrophobes
SV2008002527A (es) Composicion farmaceutica que contiene gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato ref. p-sv-80.273/ug
MX2013007807A (es) Emulsiones de aceite/agua que comprenden alcanos semifluorados.
WO2005072343A3 (en) Aqueous pharmaceutical compositions 2,6-diisopropylphenol (propofol) and their use
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
ES2570856T3 (es) Composiciones oftálmicas que contienen una combinación sinérgica de dos polímeros
ECSP099563A (es) Composiciones lubricantes personales complementarias
DE602006016127D1 (de) Zusammensetzung und dosierform mit einer festen oder halbfesten matrix
WO2008107611A3 (fr) Formulation du dimethylsulfoxyde en melange avec un additif permettant d'abaisser le point de cristallisation de ce dernier, et applications de ce melange
TR201820076T4 (tr) İlaç kombinasyonlarının salımı.
SV2005002043A (es) Dispersiones moleculares de drospirenona ref.p-sv-77.901/cd
Adefolaju et al. BAX/BCL-2 mRNA and protein expression in human breast MCF-7 cells exposed to drug vehicles-methanol and dimethyl sulfoxide (DMSO) for 24 hrs
Tang et al. Preparation of self-emulsifying drug delivery systems of Ginkgo biloba extracts and in vitro dissolution studies
CR20110685A (es) Formulaciones y métodos para mezclas que contienen quitosano sólido
Hoskins et al. The use of nano polymeric self-assemblies based on novel amphiphilic polymers for oral hydrophobic drug delivery
Soares et al. Neurotoxicity of synthetic cathinones and evaluation of putative neuroprotectors
BR112015015485A8 (pt) composição oleosa de anti-inflamatório, processo de preparação de uma composição e uso de uma composição
Sîrbu et al. TESTS FOR NSAID FORMULATION FOR HEALTHCARE
MORIO et al. Analysis on mobility of intermediate and mountainous area
Yu et al. Amphiphilic diblock copolymers based on poly (2â ethylâ 2â oxazoline) and poly (4â substitutedâ εâ caprolactone): Synthesis, characterization, and cellular uptake
CL2004001041A1 (es) Composicion farmaceutica que comprende un analeptico y un antidepresivo; uso en el tratamientonto de trastornos depresivos.
TH95064A (th) สูตรผสมในทางเภสัชกรรม

Legal Events

Date Code Title Description
FD Lapse